Cargando…
Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
The protein α-synuclein (α-Syn) has a central role in the pathogenesis of Parkinson’s disease (PD) and immunotherapeutic approaches targeting this molecule have shown promising results. In this study, novel antibodies were generated against specific peptides from full length human α-Syn and evaluate...
Autores principales: | Shahaduzzaman, Md, Nash, Kevin, Hudson, Charles, Sharif, Masroor, Grimmig, Bethany, Lin, Xiaoyang, Bai, Ge, Liu, Hui, Ugen, Kenneth E., Cao, Chuanhai, Bickford, Paula C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319932/ https://www.ncbi.nlm.nih.gov/pubmed/25658425 http://dx.doi.org/10.1371/journal.pone.0116841 |
Ejemplares similares
-
The couple of netrin-1/α-Synuclein regulates the survival of dopaminergic neurons via α-Synuclein disaggregation
por: Kang, Eun Ji, et al.
Publicado: (2023) -
Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
por: Clark, Joanne, et al.
Publicado: (2010) -
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
por: Østergaard, Freja Gam, et al.
Publicado: (2020) -
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Shan, Frank Y., et al.
Publicado: (2021) -
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
por: Hoban, Deirdre B., et al.
Publicado: (2020)